AG

Ayush Garg

Active Director Director DIN 08748016
DIN 08748016 First appointment Mar 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Mar 2021
Shareholding value •••• Premium profile

About Ayush Garg

Data last updated:

Ayush Garg is a Director at Q-Line Biotech Limited (since 2023), Director at Iq-Line Private Limited (since 2023) and Director at Asg Buildtech Private Limited (since 2021), and holds 3 more current directorships. The companies operate in Healthcare, Real Estate and Construction and Travel and Hospitality. The 5 current companies with reported revenue have a combined latest revenue of ₹331 Cr; the largest is Q-Line Biotech Limited at ₹322 Cr (FY 2025). Earlier, Ayush Garg was a Director at Acurafit Private Limited (2022–2025).

DIN 08748016
Primary Designation Director
Industry Healthcare
First Appointment 01 Mar 2021
Oldest Company Age 38 yrs
Largest company Q-Line Biotech Limited · ₹322 Cr (FY 2025)
Combined revenue ₹331 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Q-Line Biotech Limited U74120UP2010PLC042528
Director01 Jul 20232010₹322 Cr (FY 2025)Active
Iq-Line Private Limited U62011UP2023PTC186323
Director26 Jul 20232023₹7.65 Cr (FY 2025)Active
Asg Buildtech Private Limited U70100UP2018PTC100225
Director01 Mar 20212018₹1.12 Cr (FY 2025)Active
Q-Line Healthcare Private Limited U33100UP1988PTC009963
Director01 Oct 20211988₹8.2 Lakh (FY 2025)Active
Q-Line Innovations Private Limited U73100UP2022PTC175239
Director15 Apr 20232022₹15,562 (FY 2023)Active
Patheasy Diagnostics Private Limited U86905UP2025PTC228672
Director25 Jul 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acurafit Private Limited U93090UP2022PTC163490
Director04 May 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Q-Line Healthcare Private Limited
Asg Buildtech Private Limited
Q-Line Biotech Limited
Patheasy Diagnostics Private Limited
Premium access

Shareholding and investment profile for Ayush Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayush Garg

Ayush Garg currently holds 6 directorships: Q-Line Biotech Limited (Director, since 01 Jul 2023, revenue ₹322 Cr (FY 2025)); Iq-Line Private Limited (Director, since 26 Jul 2023, revenue ₹7.65 Cr (FY 2025)); Asg Buildtech Private Limited (Director, since 01 Mar 2021, revenue ₹1.12 Cr (FY 2025)); Q-Line Healthcare Private Limited (Director, since 01 Oct 2021, revenue ₹8.2 Lakh (FY 2025)); Q-Line Innovations Private Limited (Director, since 15 Apr 2023, revenue ₹15,562 (FY 2023)); and 1 more.

Ayush Garg was first appointed on 01 Mar 2021 as Director at Asg Buildtech Private Limited. The most recent appointment on record is 25 Jul 2025 at Patheasy Diagnostics Private Limited.

The 5 current companies of Ayush Garg that report revenue have a combined latest revenue of ₹331 Cr: Q-Line Biotech Limited ₹322 Cr (FY 2025); Iq-Line Private Limited ₹7.65 Cr (FY 2025); Asg Buildtech Private Limited ₹1.12 Cr (FY 2025); Q-Line Healthcare Private Limited ₹8.2 Lakh (FY 2025); Q-Line Innovations Private Limited ₹15,562 (FY 2023).

Ayush Garg held 1 earlier board appointment: Acurafit Private Limited (Director, 04 May 2022 to 15 Mar 2025).

The current boards of Ayush Garg's companies include Abhay Agrawal (Q-Line Biotech Limited), Abhishek Mishra (Q-Line Biotech Limited), Ajay Kumar Mahanty (Q-Line Biotech Limited), Akhand Pratap Singh (Q-Line Biotech Limited), Amita Garg (Q-Line Biotech Limited), Jai Prakash Singh (Q-Line Biotech Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available